Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

Zimmer Biomet Holdings, Inc.

ZBHNYSEEQUITYCurrent

Changes in Beneficial Ownership

Filed Sep 9, 2026Accepted Sep 9, 2026, 4:12 PM EDTFiling CIK 1136869Accession 0001346672-26-000010
Share

Structured filing — 4

form4-09092026_080951.xml

Open full document ↗

Filing details

Report period
2026-09-04
Issuer
ZIMMER BIOMET HOLDINGS, INC.
Issuer CIK
0001136869
Trading symbol
ZBH

Reporting owner 1

Name
Phipps Chad F
Reporting owner CIK
0001346672
Relationship
Officer
Officer title
See remarks below.
Address
345 E. MAIN STREET, WARSAW, IN, 46580

Non-derivative transactions

Non-derivative transactions · 1 reported row
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnership
Common Stock2026-09-04S · Form 43,000D98.3565,231[F1]D
Table key
S · Form 4
Sale on the market or privately
D
Direct

Footnotes

F1
Includes 471 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through July 31, 2026.↩ 1

Remarks

Senior Vice President, Chief Legal & Corporate Affairs Officer and Secretary

Signature 1

Signed
/s/ Matthew R. St. Louis, Attorney-in-Fact for Chad F. Phipps (power of attorney previously filed)
Date
2026-09-09

Company context

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.

Current securities

Recent company filings

  1. FWP filingNov 5, 2026
  2. FWP - filed by ZIMMER BIOMET HOLDINGS, INC. regarding ZIMMER BIOMET HOLDINGS, INC.Nov 5, 2026
  3. 424B5 filingNov 5, 2026
  4. 424B5 filingNov 5, 2026
  5. 10-Q filingNov 4, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.